cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.
Nature
; 584(7822): 624-629, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32788723
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dendritic Cells
/
CD4-Positive T-Lymphocytes
/
Cross-Priming
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Nature
Year:
2020
Document type:
Article
Affiliation country:
Estados Unidos